News | March 09, 2023
Evonik opens new facility for pharmaceutical lipids in Germany
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
AUR101, with a good ADME/PK profile and high bioavailability, has demonstrated inhibition of IL-17A in whole blood from psoriasis patients
Innovative Capsugel Enprotect capsule can simplify the manufacturing process to accelerate drug development and expedite first-in-human timelines
Phase 2 study to assess efficacy and safety of once daily linperlisib in patients with advanced peripheral T/NK cell lymphoma
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
Bempedoic Acid administered as a 180-mg dose, is approved by the USFDA and European Union for the treatment of hypercholesterolemia
It is a new class of drug that treats uncontrolled LDLCholesterol, despite the use of a maximum tolerated dose of statins
The companies expect to complete the submission of the NDA for treatment of MDD in the second half of 2022; associated filing for postpartum depression is anticipated in the first half of 2023
The launch is yet another first of its kind innovation in India
Subscribe To Our Newsletter & Stay Updated
